Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PepGen Inc. ( (PEPG) ) has issued an update.
On December 8, 2025, PepGen Inc. announced the appointment of Joseph Vittiglio, Esq., as Chief Business and Legal Officer. Vittiglio, who has extensive experience in legal and business leadership within the biotechnology sector, is expected to play a key role in guiding PepGen through complex transactions and strategic partnerships as the company progresses with its PGN-EDODM1 program and prepares for the 2026 readouts from its FREEDOM2-EDODM1 study.
The most recent analyst rating on (PEPG) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on PepGen Inc. stock, see the PEPG Stock Forecast page.
Spark’s Take on PEPG Stock
According to Spark, TipRanks’ AI Analyst, PEPG is a Underperform.
PepGen Inc.’s overall score reflects significant financial challenges, with limited revenue and continued losses. While technical indicators are mixed, the valuation remains unattractive due to negative earnings. Recent corporate events, including promising trial results and board expansions, offer some positive momentum but are insufficient to offset the financial concerns.
To see Spark’s full report on PEPG stock, click here.
More about PepGen Inc.
PepGen Inc. is a clinical-stage biotechnology company focused on developing next-generation oligonucleotide therapies aimed at transforming the treatment of severe neuromuscular and neurological diseases. The company’s Enhanced Delivery Oligonucleotide (EDO) platform is based on over a decade of research and utilizes cell-penetrating peptides to enhance the uptake and efficacy of conjugated oligonucleotide therapeutics.
Average Trading Volume: 3,596,134
Technical Sentiment Signal: Buy
Current Market Cap: $374M
For a thorough assessment of PEPG stock, go to TipRanks’ Stock Analysis page.